Loading...

Aurora Cannabis Inc.

ACBNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$4.54
$0.07(1.57%)

Aurora Cannabis Inc. ACB Peers

See (ACB) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ACB$4.54+1.57%255.4M23.89$0.19N/A
ZTS$159.18+0.06%70.9B28.63$5.56+1.17%
TAK$15.34-0.52%48.3B66.70$0.23+3.84%
HLN$10.25-0.10%46.1B23.84$0.43+1.14%
TEVA$17.01-0.23%19.5B-14.79-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
NBIX$129.11-0.22%12.8B43.77$2.95N/A
RDY$15.08+1.34%12.5B19.33$0.78+0.64%
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
RGC$22.99+121.91%11.4B-2299.00-$0.01N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ACB vs ZTS Comparison

ACB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACB stands at 255.4M. In comparison, ZTS has a market cap of 70.9B. Regarding current trading prices, ACB is priced at $4.54, while ZTS trades at $159.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACB currently has a P/E ratio of 23.89, whereas ZTS's P/E ratio is 28.63. In terms of profitability, ACB's ROE is +0.00%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, ACB is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for ACB.

Stock Price Comparison

Loading...

Frequently Asked Questions

;